Interleukin enhancer-binding factor 3 (ILF3) (AA 672-891) Antikörper
Kurzübersicht für Interleukin enhancer-binding factor 3 (ILF3) (AA 672-891) Antikörper (ABIN7569923)
Target
Alle Interleukin enhancer-binding factor 3 (ILF3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 672-891
-
Verwendungszweck
- Anti-Human ILF3 Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human ILF3 (Tyr672-Tyr891).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Andere Bezeichnung
- ILF3
-
Hintergrund
- ILF3, MPHOSPH4, DRBP76, TCP80, DRBF, Translational control protein 80, M-phase phosphoprotein 4, Nuclear factor associated with dsRNA, NF90, NFAR, MPP4, NF-AT-90, Double-stranded RNA-binding protein 76, Interleukin enhancer-binding factor 3, Nuclear factor of activated T-cells 90 kDa
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-